Medicine and Dentistry
Abdominal Pain
31%
Acetylsalicylic Acid
16%
Activities of Daily Living
23%
Acute Respiratory Distress Syndrome
22%
Anastomosis Leakage
31%
Angiosarcoma
18%
Apoplexy
24%
Artificial Respiration
49%
Bile Duct Injury
19%
Bleeding
49%
Body Mass Index
17%
Cancer
15%
Cancer Surgery
21%
Centenarians
18%
Cholecystectomy
30%
Chronic Pancreatitis
15%
Cohort Analysis
53%
Common Hepatic Artery
18%
Conservative Treatment
18%
COVID-19
100%
Cross Sectional Study
31%
Diagnosis
61%
Digestive System Surgery
27%
Disease Course
14%
Disease Free Survival
17%
Diseases
82%
Elective Surgery
18%
Emergency Department
21%
Empyema
18%
Esophageal Cancer
16%
Esophagectomy
39%
Geriatrics
29%
Health Care
22%
Health Care Cost
30%
Hematoma
16%
Hepatectomy
15%
Hernia
16%
Herniorrhaphy
18%
Hospital Mortality
31%
Hypoxemia
16%
Infection
62%
Injury
55%
Intensive Care
23%
Intensive Care Unit
50%
Interstitial Lung Disease
24%
Lactate Dehydrogenase
16%
Laparoscopic Cholecystectomy
60%
Life Expectancy
19%
Logistic Regression Analysis
16%
Low and Middle Income Countries
22%
Lymph Node
16%
Lymphoproliferative Disease
18%
Malignant Neoplasm
43%
Mesenteric Ischemia
15%
Meta-Analysis
65%
Metastatic Carcinoma
14%
Mortality Rate
38%
Multiple Myeloma
18%
Necrosis
16%
Neoplasm
45%
Nocardia
18%
Nutritional Assessment
13%
Observational Study
52%
Odds Ratio
35%
Outpatient
15%
Overall Survival
29%
Oxygen Saturation
26%
Pancreas Fistula
14%
Pancreaticoduodenectomy
28%
Pancreatitis
25%
Pneumothorax
23%
Postoperative Complication
20%
Prevalence
37%
Prospective Cohort Study
23%
Pseudoaneurysm
15%
Pyeloplasty
18%
Quality Improvement
19%
Quality of Life
37%
Randomized Controlled Trial
18%
Recurrent Disease
20%
Retrospective Cohort Study
14%
Retrospective Study
18%
Sepsis
26%
Septic Shock
23%
Severe Acute Respiratory Syndrome Coronavirus 2
25%
Spontaneous Pneumothorax
18%
Stoma
18%
Stomach Cancer
18%
Surgeon
15%
Surgery
88%
Surgical Anastomosis
45%
Surgical Mortality
26%
Surgical Technique
30%
Survival Time
17%
Symptom
41%
Synovial Sarcoma
18%
Systematic Review
91%
Tomography
15%
Total Hip Arthroplasty
18%
Tranexamic Acid
18%
Nursing and Health Professions
Adolescent
9%
Adult Respiratory Distress Syndrome
27%
Alka-Seltzer
9%
Alopecia Areata
9%
Altitude
18%
Anticonvulsive Agent
9%
Area under the Curve
19%
Artificial Intelligence
9%
Artificial Respiration
27%
Auditory Rehabilitation
9%
Bleeding
9%
Blood Pressure
6%
Body Mass
9%
Checklist
9%
Cholecystectomy
9%
Chronic Pain
7%
Clinical Examination
9%
Clinical Outcome
9%
Cognitive Defect
13%
Cognitive Rehabilitation
9%
Cohort Analysis
20%
Comorbidity
6%
Confidence Interval
17%
Coronary Care Unit
9%
Cross-Sectional Study
19%
Diagnosis
6%
Diagnostic Accuracy
9%
Disease
20%
Diseases
9%
Early Diagnosis
9%
Early Goal-Directed Therapy
9%
Embase
8%
Emergency Ward
9%
Evidence Based Nursing
9%
Extubation
9%
Functional Status
7%
Geriatric Care
9%
Gestational Age
6%
Golimumab
5%
Health Care Personnel
9%
Health Service
9%
Hearing Impairment
9%
Hemoglobin Determination
9%
Hernioplasty
9%
Herniorrhaphy
18%
Hip Fracture
9%
Hospital
9%
Hospital Mortality
40%
Hospitalization
12%
Infection
9%
Injury
9%
Intensive Care Unit
18%
Intermediate Care
18%
Intracranial Pressure
9%
Lactate Dehydrogenase
6%
Laparoscopic Cholecystectomy
18%
Life Expectancy
7%
Lymphocyte Count
9%
Malignant Neoplasm
9%
Medline
8%
Meta Analysis
28%
Minoxidil
9%
Mortality Rate
6%
Multiple Sclerosis
9%
Muscle Mass
9%
Muscle Thickness
9%
Neck Injury
9%
Necrosis
7%
Neonatal Intensive Care Unit
9%
Network Meta-Analysis
18%
Neutrophil Lymphocyte Ratio
9%
New-Onset Atrial Fibrillation
9%
Normal Value
9%
Nursing Assistant
9%
Nursing Staff
18%
Nutrition Assessment
6%
Nutritional Assessment
9%
Patient Population
9%
Placebo
7%
Practice Guideline
6%
Predictive Value
6%
Prevalence
9%
Procalcitonin
9%
Pyeloplasty
9%
Quality of Life
21%
Receiver Operating Characteristic
11%
Recurrent Disease
9%
Reverse Transcription Polymerase Chain Reaction
9%
Sarcopenia
5%
Sedation
9%
Severe Acute Respiratory Syndrome
9%
Surgery
9%
Systematic Review
36%
Tertiary Care Center
9%
Total Hip Prosthesis
9%
Tracheal Intubation
9%
Tracheostomy
9%
Tranexamic Acid
9%
Tumor Necrosis
9%
Volunteer
9%
Pharmacology, Toxicology and Pharmaceutical Science
Abdominal Infection
9%
Acetylsalicylic Acid
6%
Acute Appendicitis
9%
Adult Respiratory Distress Syndrome
11%
Adverse Event
10%
Alopecia Areata
9%
Antibiotic Prophylaxis
9%
Anticonvulsive Agent
9%
Antiphospholipid Syndrome
9%
Autoantibodies
9%
Base
18%
Bile Duct Fistula
9%
Bile Leakage
9%
Bovine Leukemia Virus
9%
Brain Abscess
9%
Bronchitis
9%
Cannabidiol
9%
Cardiomyopathy
9%
Cardiovascular Risk
9%
Cholecystitis
9%
Chronic Diarrhea
9%
Chronic Disease
9%
Chronic Obstructive Lung Disease
9%
Chronic Pain
9%
Ciclonicate
9%
Cohort Study
10%
Collagen Type 1
9%
Common Bile Duct Stone
9%
Comorbidity
15%
Connective Tissue Disease
9%
Contrast Induced Nephropathy
9%
Coronavirinae
18%
Coughing
19%
Disease
15%
Diseases
9%
Diuretic Agent
9%
Ecological Study
9%
Eosinophilic Gastroenteritis
9%
Frailty
9%
Gallstone
9%
Gamma Ray
9%
Genetic Risk
9%
Headache
9%
Heart Arrest
9%
Hip Fracture
9%
Hospital Mortality
9%
Hypoxemia
9%
Ileum
9%
Infection
11%
Interstitial Lung Disease
18%
Ivy
9%
Kidney Infarction
9%
Lactate Dehydrogenase
6%
Life Expectancy
12%
Liver Metastasis
9%
Low Back Pain
6%
Malignant Neoplasm
11%
Methotrexate
9%
Mild Cognitive Impairment
9%
Minoxidil
9%
Morbidity
9%
Mortality Rate
13%
Multiple Myeloma
9%
Multiple Sclerosis
9%
Mycobacterium Tuberculosis
9%
Neuroendocrine Tumor
9%
New-Onset Atrial Fibrillation
9%
Nocardia
9%
Non Small Cell Lung Cancer
9%
Nutrition Supplement
9%
Observational Study
28%
Ovary Polycystic Disease
9%
Pancreas Islet Cell Tumor
6%
Placebo
16%
Postoperative Complication
9%
Prevalence
9%
Primary Headache
9%
Prospective Cohort Study
11%
Randomized Controlled Trial
9%
Recurrent Disease
9%
Restenosis
9%
Rhabdomyolysis
9%
Rosuvastatin
9%
SARS Coronavirus
11%
Scleroderma
6%
Solitary Fibrous Tumor
9%
Stenosis
9%
Stomach Cancer
9%
Stomach Paresis
9%
Syndrome
12%
Systemic Sclerosis
9%
Tigecycline
9%
Tranexamic Acid
9%
Tree
9%
Tumor Necrosis
9%
Tumor Necrosis Factor
9%
Ulcer Perforation
9%
Urinary Tract Infection
9%
Vaccination Policy
9%
Vasoactive Intestinal Polypeptide
6%